Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Assets (2019 - 2023)

Historic Assets for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $466.9 million.

  • ADC Therapeutics' Assets fell 1219.71% to $466.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $466.9 million, marking a year-over-year decrease of 1219.71%. This contributed to the annual value of $490.9 million for FY2022, which is 7933062.15% up from last year.
  • Latest data reveals that ADC Therapeutics reported Assets of $466.9 million as of Q3 2023, which was down 1219.71% from $507.3 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Assets ranged from a high of $638.0 million in Q3 2021 and a low of $137682.0 during Q4 2019
  • In the last 5 years, ADC Therapeutics' Assets had a median value of $479.3 million in 2022 and averaged $401.7 million.
  • As far as peak fluctuations go, ADC Therapeutics' Assets skyrocketed by 12411985.76% in 2021, and later plummeted by 1962.82% in 2023.
  • Over the past 5 years, ADC Therapeutics' Assets (Quarter) stood at $137682.0 in 2019, then soared by 278.79% to $521526.0 in 2020, then skyrocketed by 94129.37% to $491.4 million in 2021, then decreased by 0.12% to $490.9 million in 2022, then decreased by 4.88% to $466.9 million in 2023.
  • Its Assets was $466.9 million in Q3 2023, compared to $507.3 million in Q2 2023 and $467.7 million in Q1 2023.